Kelly Copes-Anderson

Kelly Copes-Anderson serves as the Vice President of Cardiometabolic Healthcare Access at Eli Lilly and Company, a role focused on advancing equity-driven strategies for underserved populations impacted by obesity. With a robust career at Eli Lilly since 1995, Kelly has also held positions such as Vice President of Diversity, Equity, and Inclusion, where initiatives led to significant cultural shifts within the organization. As the Global Brand Leader for Verzenio, Kelly played a pivotal role in launching a successful breast cancer product across over 90 countries. Other notable achievements include enhancing the global marketing strategy for Effient and leading a market research team that contributed to transforming an oncology portfolio. Kelly holds an MBA in Marketing and a BS in Chemical Engineering, complemented by a certification from the Harvard Business Analytics Program.